Trial Outcomes & Findings for A Study of the Effectiveness and Efficacy of the PowerSleep Device (NCT NCT03162328)
NCT ID: NCT03162328
Last Updated: 2021-03-24
Results Overview
It is hypothesized that the use of active PowerSleep over two work nights of use, as compared to the sham device over two work nights of use, will result in a significant increase (≥5%), in mean total slow-wave activity (SWA). Slow wave activity (SWA) corresponds to the EEG power in the 0.5 to 4 Hz band during non-rapid eye movement (NREM) sleep. SWA reflects the number and amplitude of slow-waves and determines the speed with which sleep-need dissipates.
COMPLETED
NA
84 participants
4 nights
2021-03-24
Participant Flow
84 participants across 7 sites were screened for eligibility for this study. Recruitment was open April 2017 through November 2017.
Of the 84 participants screened, 63 were found to be eligible,however 1 eligible participant withdrew at the randomization visit, but prior to randomization. 1 participant withdrew after being randomized. 1 participant did not complete all study visits, but had enough device data to be included in the analysis.
Participant milestones
| Measure |
Screening Population
All patients that signed consent are considered for the screening population.
|
Powersleep Sham, PowerSleep Stim
Participants wear the same PowerSleep device as with the active treatment, however no audio tones will be administered via the speakers. After 2 nights in the lab in the sham condition participants will cross-over to the other arm of the trial the following week. Week 2 - Participants will wear the PowerSleep device with soft audio tones administered via the speakers during deep sleep throughout the night.
PowerSleep Stim: Participants will wear the PowerSleep device with soft audio tones administered via the speakers during deep sleep throughout the night.
PowerSleep Sham: Participants wear the same PowerSleep device as with the active treatment, however no audio tones will be administered via the speakers.
|
Powersleep Stim, PowerSleep Sham
Participants will wear the PowerSleep device with soft audio tones administered via the speakers during deep sleep throughout the night. After 2 nights in the lab in the stim condition participants will cross-over to the other arm of the trial the following week. Week 2 - Participants wear the same PowerSleep device as with the active treatment, however no audio tones will be administered via the speakers.
PowerSleep Stim: Participants will wear the PowerSleep device with soft audio tones administered via the speakers during deep sleep throughout the night.
PowerSleep Sham: Participants wear the same PowerSleep device as with the active treatment, however no audio tones will be administered via the speakers.
|
|---|---|---|---|
|
Screening Period
STARTED
|
84
|
0
|
0
|
|
Screening Period
COMPLETED
|
62
|
0
|
0
|
|
Screening Period
NOT COMPLETED
|
22
|
0
|
0
|
|
Study Period
STARTED
|
0
|
30
|
32
|
|
Study Period
COMPLETED
|
0
|
30
|
31
|
|
Study Period
NOT COMPLETED
|
0
|
0
|
1
|
Reasons for withdrawal
| Measure |
Screening Population
All patients that signed consent are considered for the screening population.
|
Powersleep Sham, PowerSleep Stim
Participants wear the same PowerSleep device as with the active treatment, however no audio tones will be administered via the speakers. After 2 nights in the lab in the sham condition participants will cross-over to the other arm of the trial the following week. Week 2 - Participants will wear the PowerSleep device with soft audio tones administered via the speakers during deep sleep throughout the night.
PowerSleep Stim: Participants will wear the PowerSleep device with soft audio tones administered via the speakers during deep sleep throughout the night.
PowerSleep Sham: Participants wear the same PowerSleep device as with the active treatment, however no audio tones will be administered via the speakers.
|
Powersleep Stim, PowerSleep Sham
Participants will wear the PowerSleep device with soft audio tones administered via the speakers during deep sleep throughout the night. After 2 nights in the lab in the stim condition participants will cross-over to the other arm of the trial the following week. Week 2 - Participants wear the same PowerSleep device as with the active treatment, however no audio tones will be administered via the speakers.
PowerSleep Stim: Participants will wear the PowerSleep device with soft audio tones administered via the speakers during deep sleep throughout the night.
PowerSleep Sham: Participants wear the same PowerSleep device as with the active treatment, however no audio tones will be administered via the speakers.
|
|---|---|---|---|
|
Screening Period
Did not meet inclusion/exclusion
|
21
|
0
|
0
|
|
Screening Period
Withdrawal by Subject
|
1
|
0
|
0
|
|
Study Period
Withdrawal by Subject
|
0
|
0
|
1
|
Baseline Characteristics
A Study of the Effectiveness and Efficacy of the PowerSleep Device
Baseline characteristics by cohort
| Measure |
Screening Population
n=84 Participants
All patients that signed consent are considered for the screening population.
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=99 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
84 Participants
n=99 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=99 Participants
|
|
Age, Continuous
|
32.70 years
STANDARD_DEVIATION 8.04 • n=99 Participants
|
|
Sex: Female, Male
Female
|
49 Participants
n=99 Participants
|
|
Sex: Female, Male
Male
|
35 Participants
n=99 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
12 Participants
n=99 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
72 Participants
n=99 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=99 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=99 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=99 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=99 Participants
|
|
Race (NIH/OMB)
Black or African American
|
25 Participants
n=99 Participants
|
|
Race (NIH/OMB)
White
|
55 Participants
n=99 Participants
|
|
Race (NIH/OMB)
More than one race
|
4 Participants
n=99 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=99 Participants
|
|
Region of Enrollment
United States
|
84 participants
n=99 Participants
|
|
Body Mass Index
|
26.79 kg/m^2
STANDARD_DEVIATION 5.14 • n=99 Participants
|
|
Heart Rate
|
71.38 beats per minute
STANDARD_DEVIATION 10.77 • n=99 Participants
|
|
Blood Pressure- Systolic
|
118.80 mmHg
STANDARD_DEVIATION 15.71 • n=99 Participants
|
|
Blood Pressure- Diastolic
|
76.42 mmHg
STANDARD_DEVIATION 10.58 • n=99 Participants
|
|
Epworth Sleepiness Scale Total
|
5.48 units on a scale
STANDARD_DEVIATION 3.74 • n=99 Participants
|
|
insomnia severity index
|
7.31 units on a scale
STANDARD_DEVIATION 5.33 • n=99 Participants
|
|
Temperature
|
97.76 degrees Farenheit
STANDARD_DEVIATION 0.89 • n=99 Participants
|
|
Weight
|
172.48 pounds
STANDARD_DEVIATION 41.80 • n=99 Participants
|
|
Neck Circumference
|
35.09 centimeters
STANDARD_DEVIATION 3.93 • n=99 Participants
|
PRIMARY outcome
Timeframe: 4 nightsPopulation: 5 data sets were lost in the Sham/Stim condition: 1 - noisy data, 4 - not crossed over 4 data sets were lost in the Stim/Sham condition: 4 - not crossed over
It is hypothesized that the use of active PowerSleep over two work nights of use, as compared to the sham device over two work nights of use, will result in a significant increase (≥5%), in mean total slow-wave activity (SWA). Slow wave activity (SWA) corresponds to the EEG power in the 0.5 to 4 Hz band during non-rapid eye movement (NREM) sleep. SWA reflects the number and amplitude of slow-waves and determines the speed with which sleep-need dissipates.
Outcome measures
| Measure |
Powersleep Sham
n=52 Participants
PowerSleep Sham: Participants wear the same PowerSleep device as with the active treatment, however no audio tones will be administered via the speakers.
|
PowerSleep Stim
n=52 Participants
PowerSleep Stim: Participants will wear the PowerSleep device with soft audio tones administered via the speakers during deep sleep throughout the night.
|
|---|---|---|
|
Average Amount of Slow Wave Activity Delivered by the Powersleep Device With and Without Stimulation
|
1649.41 microvolts^2
Standard Deviation 896.05
|
1643.84 microvolts^2
Standard Deviation 847.34
|
PRIMARY outcome
Timeframe: 4 nightsPopulation: 5 data sets were lost in the Sham/Stim condition: 1 - noisy data, 4 - not crossed over 4 data sets were lost in the Stim/Sham condition: 4 - not crossed over
It is hypothesized that the use of active PowerSleep over two work nights of use, as compared to the sham device over two works nights of use, will result in a significant increase (≥5%), in mean total slow-wave activity (SWA).The integral of SWA (CSWA) over a sleep session, is directly proportional to the sleep-need dissipation occurring during said sleep session. In our research, both SWA and CSWA are evaluated as relative values having as reference the average SWA and CSWA over sham sleep sessions. CSWA is the integral of SWA which is why the unit of CSWA is microvolt\^2×minute.
Outcome measures
| Measure |
Powersleep Sham
n=52 Participants
PowerSleep Sham: Participants wear the same PowerSleep device as with the active treatment, however no audio tones will be administered via the speakers.
|
PowerSleep Stim
n=52 Participants
PowerSleep Stim: Participants will wear the PowerSleep device with soft audio tones administered via the speakers during deep sleep throughout the night.
|
|---|---|---|
|
Cumulative Amount of Slow Wave Activity Delivered by the Powersleep Device With and Without Stimulation
|
1437304 microvolts^2×minute
Standard Deviation 1290198
|
1444740 microvolts^2×minute
Standard Deviation 1220632
|
SECONDARY outcome
Timeframe: 4 nightsPopulation: 1 participant was excluded from the analysis because of a nap in between treatment nights 1 participant was excluded from the analysis because they did not complete the final night of the study 4 data sets were lost in the Sham/Stim condition: 4 - not crossed over 4 data sets were lost in the Stim/Sham condition: 4 - not crossed over
To evaluate the relationship between MSLT (sleep latency) and changes in SWA. This evaluated the average length of time it took a participant to fall asleep (in minutes) for each of the 4 naps in each condition, after two nights of sham and two nights of stim.
Outcome measures
| Measure |
Powersleep Sham
n=51 Participants
PowerSleep Sham: Participants wear the same PowerSleep device as with the active treatment, however no audio tones will be administered via the speakers.
|
PowerSleep Stim
n=51 Participants
PowerSleep Stim: Participants will wear the PowerSleep device with soft audio tones administered via the speakers during deep sleep throughout the night.
|
|---|---|---|
|
Changes in Multiple Sleep Latency Test (MSLT)
|
10.3 minutes
Standard Deviation 5.4
|
10.3 minutes
Standard Deviation 5.3
|
SECONDARY outcome
Timeframe: 4 nightsPopulation: 1 participant was excluded from the analysis because they did not complete the final night of the study 4 data sets were lost in the Sham/Stim condition: 4 - not crossed over 4 data sets were lost in the Stim/Sham condition: 4 - not crossed over 1 participant did not complete the learning in the evening therefore data was unscorable.
To measure trends of memory of 2 weeks of home use randomized with active PowerSleep (delivering audio tones) as compared to a two weeks of sham (delivering no audio tones). Participants answered completed an 80 word pair memory recall in the morning following the overnight in the sleep lab. The results listed below are the mean and standard deviation of the PowerSleep treatment week compared to the Sham treatment week. Learning was completed on the last night in the lab in each arm, with recall in the morning. PAL Differences (morning - evening responses): Difference between number correct the morning recall and the evening recall Correct Responses (evening recall): number of correct responses during the evening recall Correct Responses (morning call): number of correct responses during the morning recall, after the night in the sleep lab.
Outcome measures
| Measure |
Powersleep Sham
n=51 Participants
PowerSleep Sham: Participants wear the same PowerSleep device as with the active treatment, however no audio tones will be administered via the speakers.
|
PowerSleep Stim
n=51 Participants
PowerSleep Stim: Participants will wear the PowerSleep device with soft audio tones administered via the speakers during deep sleep throughout the night.
|
|---|---|---|
|
Paired Associates Learning (PAL)
PAL Differences (morning - evening responses)
|
7.45 number of words
Standard Deviation 8.38
|
8.51 number of words
Standard Deviation 7.5
|
|
Paired Associates Learning (PAL)
Correct Responses (evening recall)
|
21.76 number of words
Standard Deviation 10.74
|
23.82 number of words
Standard Deviation 14.37
|
|
Paired Associates Learning (PAL)
Correct Responses (morning recall)
|
29.22 number of words
Standard Deviation 12.11
|
32.33 number of words
Standard Deviation 17.19
|
SECONDARY outcome
Timeframe: 4 nightsPopulation: 5 participants did not have verbal fluency recorded therefore were unable to be scored 1 participant was excluded from the analysis because they did not complete the final night of the study 1 participant was excluded because they had to repeat second work week 8 data sets were lost because they were not crossed over
To evaluate the relationship between cognitive testing changes and changes in SWA. Verbal fluency is a type of cognitive testing in which participants are required to generate as many words directly related to the instructions as they can. This task has three conditions each arm:letter fluency (F,A,S and B,H,R),category fluency (Animals, Boys names and clothing girls names) and category switching (Fruits and furniture and vegetables and musical instruments). Each trial with each condition lasts for 60 seconds. Total correct responses are calculated by counting the number of correct words generated for each condition: letter fluency, category fluency and switching Total repetition errors are calculated by counting any response that is repeated within the 60sec trial for each condition. Total set-loss errors are any response that violates any of the criterion rules of the condition (for example saying Bill instead of Beth for girls names) for each condition.
Outcome measures
| Measure |
Powersleep Sham
n=46 Participants
PowerSleep Sham: Participants wear the same PowerSleep device as with the active treatment, however no audio tones will be administered via the speakers.
|
PowerSleep Stim
n=46 Participants
PowerSleep Stim: Participants will wear the PowerSleep device with soft audio tones administered via the speakers during deep sleep throughout the night.
|
|---|---|---|
|
Changes in Cognitive Testing - Verbal Fluency
Category Fluency - Total Correct
|
42.5 words
Standard Deviation 8.15
|
42.52 words
Standard Deviation 7.77
|
|
Changes in Cognitive Testing - Verbal Fluency
Category Fluency - Total Repetition Errors
|
1.04 words
Standard Deviation 1.11
|
0.74 words
Standard Deviation 1.06
|
|
Changes in Cognitive Testing - Verbal Fluency
Category Fluency - Total Set Loss Errors
|
0.7 words
Standard Deviation 1.59
|
0.61 words
Standard Deviation 1.16
|
|
Changes in Cognitive Testing - Verbal Fluency
Category Switching - Number Correct
|
14.67 words
Standard Deviation 2.25
|
13.8 words
Standard Deviation 2.55
|
|
Changes in Cognitive Testing - Verbal Fluency
Category Switching - Number of Repetition Errors
|
0.17 words
Standard Deviation 0.49
|
0.39 words
Standard Deviation 0.71
|
|
Changes in Cognitive Testing - Verbal Fluency
Category Switching - Number of Set Loss Errors
|
0.35 words
Standard Deviation 0.74
|
0.37 words
Standard Deviation 0.80
|
|
Changes in Cognitive Testing - Verbal Fluency
Letter Fluency - Total Correct
|
38.28 words
Standard Deviation 9.36
|
38.72 words
Standard Deviation 11.35
|
|
Changes in Cognitive Testing - Verbal Fluency
Letter Fluency - Total Repetition Errors
|
0.98 words
Standard Deviation 1.29
|
1.26 words
Standard Deviation 1.5
|
|
Changes in Cognitive Testing - Verbal Fluency
Letter Fluency - Total Set Loss Errors
|
0.63 words
Standard Deviation 0.9
|
0.41 words
Standard Deviation 1.15
|
SECONDARY outcome
Timeframe: 2 days following each intervention, over 9 daysPopulation: 8 data sets were lost in the analysis as participants were randomized but not crossed over to the other arm of the study. 1 data set was lost because the wrong form was administered. 1 participant did not complete the final overnight
Average subjective sleepiness scales, as measured by scores on a scale of 0 to 10, PowerSleep Sham over 2 works nights of use as compared to PowerSleep Stim over 2 works nights of use. For these outcomes the 0 was the worst, 10 being the best. Sleepiness scales were completed each morning following after the 2 nights of the one condition and the 2 nights in the other condition. The values of 2 nights (mornings after) are averaged and compared to the average of the 2 nights the following week. Therefore the timeframe is 4 nights.
Outcome measures
| Measure |
Powersleep Sham
n=51 Participants
PowerSleep Sham: Participants wear the same PowerSleep device as with the active treatment, however no audio tones will be administered via the speakers.
|
PowerSleep Stim
n=51 Participants
PowerSleep Stim: Participants will wear the PowerSleep device with soft audio tones administered via the speakers during deep sleep throughout the night.
|
|---|---|---|
|
Average Subjective Sleepiness Scales.
How alert you feel?
|
6.36 score on a scale
Standard Deviation 2.18
|
6.61 score on a scale
Standard Deviation 2.19
|
|
Average Subjective Sleepiness Scales.
How deep was your sleep?
|
6.25 score on a scale
Standard Deviation 2.13
|
6.52 score on a scale
Standard Deviation 1.99
|
|
Average Subjective Sleepiness Scales.
How mentally refreshed you feel?
|
6.35 score on a scale
Standard Deviation 2.07
|
6.68 score on a scale
Standard Deviation 2.11
|
|
Average Subjective Sleepiness Scales.
Rate your sleep quality?
|
6.18 score on a scale
Standard Deviation 2.11
|
6.38 score on a scale
Standard Deviation 2.08
|
SECONDARY outcome
Timeframe: 2 days following each intervention, over 9 daysPopulation: 4 data sets were lost in the Sham/Stim condition: 4 - not crossed over 4 data sets were lost in the Stim/Sham condition: 4 - not crossed over 1 participant napped between overnights and was excluded from the daytime measures 1 participant did not complete the final overnight
Average subjective sleepiness between PowerSleep Sham nights as compared to PowerSleep Stim nights on the Karolinska Sleepiness Scale 1 - very alert, 9 - very sleepy, great effort to keep awake Sleepiness scales were completed each morning following after the 2 nights of the one condition and the 2 nights in the other condition. The averages of the 2 nights (mornings after) are compared to the averages of the 2 nights (mornings after) the following week. Therefore the timeframe is 4 nights.
Outcome measures
| Measure |
Powersleep Sham
n=51 Participants
PowerSleep Sham: Participants wear the same PowerSleep device as with the active treatment, however no audio tones will be administered via the speakers.
|
PowerSleep Stim
n=51 Participants
PowerSleep Stim: Participants will wear the PowerSleep device with soft audio tones administered via the speakers during deep sleep throughout the night.
|
|---|---|---|
|
Average Subjective Sleepiness Scale- Karolinska Sleepiness Scale
|
3.97 score on a scale
Standard Deviation 1.62
|
3.76 score on a scale
Standard Deviation 1.97
|
SECONDARY outcome
Timeframe: 2 days following each intervention, over 9 daysPopulation: 8 data sets were lost as participants were not crossed over to the other arm of the trial. 1 participant napped between overnights and was excluded from the daytime measures 1 participant did not complete the final overnight
Average subjective sleepiness between PowerSleep Sham as compared to PowerSleep Stim on the Samn Perelli questionnaire 1 - fully alert, wide awake, extremely peppy and 7 - completely exhausted, unable to function effectively, ready to drop Sleepiness scales were completed each morning following after the 2 nights of the one condition and the 2 nights in the other condition. The averages of the 2 nights (mornings after) are compared to the average of the 2 nights(mornings after) the following week. Therefore the timeframe is 4 nights.
Outcome measures
| Measure |
Powersleep Sham
n=51 Participants
PowerSleep Sham: Participants wear the same PowerSleep device as with the active treatment, however no audio tones will be administered via the speakers.
|
PowerSleep Stim
n=51 Participants
PowerSleep Stim: Participants will wear the PowerSleep device with soft audio tones administered via the speakers during deep sleep throughout the night.
|
|---|---|---|
|
Average of Subjective Sleepiness Scale- Samn Perelli
|
3.07 score on a scale
Standard Deviation 1.06
|
2.88 score on a scale
Standard Deviation 1.26
|
SECONDARY outcome
Timeframe: 4 nightsPopulation: 2 participants completed the wrong PVT 1 participant did not complete the final overnight 1 participant did not complete the PVT after wake-up 8 data sets were lost as participants did not cross over 1 participant napped in between overnights and the data was no usable
To measure trends of vigilance of (2 nights) of home use randomized with active PowerSleep (delivering audio tones) as compared to (2 nights) of sham (delivering no audio tones). This measured how quickly participants reacted to visual stimulus. Reaction time is the latency at which the participant reacts to a visual stimulus \> 100 ms.
Outcome measures
| Measure |
Powersleep Sham
n=48 Participants
PowerSleep Sham: Participants wear the same PowerSleep device as with the active treatment, however no audio tones will be administered via the speakers.
|
PowerSleep Stim
n=48 Participants
PowerSleep Stim: Participants will wear the PowerSleep device with soft audio tones administered via the speakers during deep sleep throughout the night.
|
|---|---|---|
|
Psychomotor Vigilance Test - Reaction Times
Average 10% fastest reaction time
|
192.59 milliseconds
Standard Deviation 14.68
|
187.97 milliseconds
Standard Deviation 16.72
|
|
Psychomotor Vigilance Test - Reaction Times
Average reaction time
|
258.77 milliseconds
Standard Deviation 32.78
|
254.24 milliseconds
Standard Deviation 38.00
|
|
Psychomotor Vigilance Test - Reaction Times
Average 10% slowest reaction time
|
433.16 milliseconds
Standard Deviation 128.13
|
428.07 milliseconds
Standard Deviation 180.61
|
SECONDARY outcome
Timeframe: 4 nightsPopulation: 2 participants completed the wrong PVT 1 participant did not complete the final overnight 1 participant did not complete the PVT after wake-up 8 data sets were lost as participants did not cross over 1 participant napped in between overnights and the data was no usable
To measure trends of vigilance of (2 nights) of home use randomized with active PowerSleep (delivering audio tones) as compared to (2 nights) of sham (delivering no audio tones). Anticipations are the increase in errors of commission (responses without a stimulus) response time \<100ms. Lapses (errors of omission) are measured or usually defined as reaction Times ≥ 500 ms.
Outcome measures
| Measure |
Powersleep Sham
n=48 Participants
PowerSleep Sham: Participants wear the same PowerSleep device as with the active treatment, however no audio tones will be administered via the speakers.
|
PowerSleep Stim
n=48 Participants
PowerSleep Stim: Participants will wear the PowerSleep device with soft audio tones administered via the speakers during deep sleep throughout the night.
|
|---|---|---|
|
Psychomotor Vigilance Test - Number of Anticipation and Number of Lapses.
Number of anticipations
|
4.35 count of events
Standard Deviation 5.29
|
5.77 count of events
Standard Deviation 10.92
|
|
Psychomotor Vigilance Test - Number of Anticipation and Number of Lapses.
Number of Lapses
|
4.9 count of events
Standard Deviation 5.2
|
3.9 count of events
Standard Deviation 4.83
|
SECONDARY outcome
Timeframe: 4 nightsPopulation: 2 participants completed the wrong PVT 1 participant did not complete the final overnight 1 participant did not complete the PVT after wake-up 8 data sets were lost as participants did not cross over 1 participant napped in between overnights and the data was no usable
To measure trends of vigilance of (2 nights) of home use randomized with active PowerSleep (delivering audio tones) as compared to (2 nights) of sham (delivering no audio tones). This measured the average speed with which participants respond to a visual stimulus. The average speed is 1/RT (also called reciprocal response time or response speed).
Outcome measures
| Measure |
Powersleep Sham
n=48 Participants
PowerSleep Sham: Participants wear the same PowerSleep device as with the active treatment, however no audio tones will be administered via the speakers.
|
PowerSleep Stim
n=48 Participants
PowerSleep Stim: Participants will wear the PowerSleep device with soft audio tones administered via the speakers during deep sleep throughout the night.
|
|---|---|---|
|
Psychomotor Vigilance Test - Average Speed
|
4.14 1/s
Standard Deviation 0.43
|
4.22 1/s
Standard Deviation 0.39
|
Adverse Events
Screening Period
PowerSleep Sham, PowerSleep Stim
Powersleep Stim, PowerSleep Sham
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place